Stay updated on Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial

Sign up to get notified when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.5.3 to v3.5.4, indicating a new revision of the page; this appears to be a minor update to the page metadata rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-05-20T09:21:14.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The study locations list has expanded to 421 sites worldwide, with new institutions added (e.g., Khmelnytskyi, Ukraine; Kirkland, Washington; Zagreb, Croatia; Tampa, Florida) and existing entries updated. New investigator contacts and site details have been added, and recruitment statuses across sites have been clarified (Recruiting, Withdrawn, Completed).
    Difference
    0.8%
    Check dated 2026-05-13T06:58:08.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.2 to v3.5.3, indicating a new build of the page. This update serves to track revisions to the page's documentation.
    Difference
    0.0%
    Check dated 2026-04-28T22:15:02.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The number of study locations increased (415 to 416) with corresponding additions/updates to specific site and local institution entries and their contact information (e.g., a new location/site in Ternopil, Ukraine and updated contacts). The page also reflects a newer record update date and revision entry.
    Difference
    0.5%
    Check dated 2026-04-21T15:56:22.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added new study locations: Site 8007 (Lviv, Ukraine); Site 8004 (Smila, Ukraine); Site 4216 (Sochaczew, Poland), bringing the total number of locations to 415. Removed previously listed sites (e.g., Yokohama 231-0801; Site 4214; Site 7218) and updated related Tampa location details.
    Difference
    0.3%
    Check dated 2026-04-13T13:41:06.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Added sponsor Karuna Therapeutics, Inc., a Bristol Myers Squibb company and multiple recruitment sites with contacts (South Florida Research Phase I-IV - Miami; AMC Research, LLC - Flourish - PPDS; Sveti Georgi EAD-66 Peshtersko Shosse blvd) and their phone numbers. Removed sponsor Karuna Therapeutics and local sites 1053, 1214, 4508 and their contacts.
    Difference
    0.2%
    Check dated 2026-03-30T02:23:09.000Z thumbnail image

Stay in the know with updates to Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.